Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04071470Completed
Randomised, open-label trial (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Adherence to PrEP Medication at 3 months. Started Jan 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04071470.